Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED BALANCE SHEETS

v3.25.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2025
Mar. 31, 2024
Current assets:    
Cash and cash equivalents $ 16,464 $ 25,692
Restricted cash 139 168
Accounts receivable, net of allowance for credit losses of $99 and $22, respectively 52,502 67,788
Manufacturing inventories 20,336 17,753
Service parts inventories 2,098 9,783
Prepaid expenses 2,738 2,186
Other current assets 8,529 8,414
Total current assets 102,806 131,784
Property and equipment, net 11,378 12,028
Intangible assets, net 281 1,669
Goodwill 12,969 12,969
Right-of-use assets, net 8,580 9,425
Other long-term assets 19,388 19,740
Total assets 155,402 187,615
Current liabilities:    
Accounts payable 31,463 26,087
Accrued compensation 9,214 18,214
Deferred revenue, current portion 75,076 78,511
Accrued restructuring charges 786 0
Term debt 96,486 82,496
Revolving credit facility 26,600 26,604
Warrant liabilities 0 4,046
Other accrued liabilities 17,982 13,986
Total current liabilities 257,607 249,944
Deferred revenue, net of current portion 38,847 38,176
Operating lease liabilities 8,934 9,621
Other long-term liabilities 14,380 11,372
Total liabilities 319,768 309,113
Commitments and Contingencies (Note 10)
Preferred stock:    
Preferred stock, 20,000 shares authorized; no shares issued as of March 31, 2025 and 2024, respectively 0 0
Common stock:    
Common stock, $0.01 par value; 225,000 shares authorized; 6,962 and 4,792 shares issued and outstanding at March 31, 2025 and 2024, respectively 70 48
Additional paid-in capital 779,645 708,027
Accumulated deficit (942,471) (827,380)
Accumulated other comprehensive loss (1,610) (2,193)
Total stockholders' deficit (164,366) (121,498)
Total liabilities and stockholders' deficit $ 155,402 $ 187,615